{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T18:02:09Z","timestamp":1770314529057,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:00:00Z","timestamp":1768608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:00:00Z","timestamp":1768608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Peking University People\u2019s Hospital Scientific Research Development Funds","award":["RZ2023-04"],"award-info":[{"award-number":["RZ2023-04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-06761-3","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T01:14:16Z","timestamp":1768612456000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Paediatric blastic plasmacytoid dendritic cell neoplasm: a single-centre case series of 18 children and review of the literature"],"prefix":"10.1007","volume":"105","author":[{"given":"Zhi-xiao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai-dong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le-ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue-ping","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengrong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-min","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,17]]},"reference":[{"issue":"1","key":"6761_CR1","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1038\/s41467-022-29669-8","volume":"13","author":"T Cai","year":"2022","unstructured":"Cai T, Gouble A, Black KL, Skwarska A, Naqvi AS, Taylor D, Zhao M, Yuan Q, Sugita M, Zhang Q, Galetto R, Filipe S, Cavazos A, Han L, Kuruvilla V, Ma H, Weng C, Liu CG, Liu X, Konoplev S, Konopleva M (2022) Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells. Nat Commun 13(1):2228. https:\/\/doi.org\/10.1038\/s41467-022-29669-8","journal-title":"Nat Commun"},{"key":"6761_CR2","volume-title":"WHO classification of tumours of Haematopoietic and lymphoid tissues","author":"SH Swerdlow","year":"2017","unstructured":"Swerdlow SH, Campo E, Harris NL et al (2017) WHO classification of tumours of Haematopoietic and lymphoid tissues, vol 2, 4th edn. International Agency for Research on Cancer, Lyon","edition":"4"},{"issue":"19","key":"6761_CR3","doi-asserted-by":"publisher","first-page":"4838","DOI":"10.1182\/bloodadvances.2020002474","volume":"4","author":"K Laribi","year":"2020","unstructured":"Laribi K, Baugier de Materre A, Sobh M, Cerroni L, Valentini CG, Aoki T, Suzuki R, Takeuchi K, Frankel AE, Cota C, Ghez D, Le Calloch R, Pagano L, Petrella T (2020) Blastic plasmacytoid dendritic cell neoplasms: results of an international survey on 398 adult patients. Blood Adv 4(19):4838\u20134848. https:\/\/doi.org\/10.1182\/bloodadvances.2020002474","journal-title":"Blood Adv"},{"issue":"9","key":"6761_CR4","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1038\/s41375-023-01968-z","volume":"37","author":"B Cuglievan","year":"2023","unstructured":"Cuglievan B, Connors J, He J, Khazal S, Yedururi S, Dai J, Garces S, Quesada AE, Roth M, Garcia M, McCall D, Gibson A, Ragoonanan D, Petropoulos D, Tewari P, Nunez C, Mahadeo KM, Tasian SK, Lamble AJ, Pawlowska A, Pemmaraju N (2023) Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies. Leukemia 37(9):1767\u20131778. https:\/\/doi.org\/10.1038\/s41375-023-01968-z","journal-title":"Leukemia"},{"issue":"7","key":"6761_CR5","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1038\/leu.2017.101","volume":"31","author":"K Suzuki","year":"2017","unstructured":"Suzuki K, Suzuki Y, Hama A, Muramatsu H, Nakatochi M, Gunji M, Ichikawa D, Hamada M, Taniguchi R, Kataoka S, Murakami N, Kojima D, Sekiya Y, Nishikawa E, Kawashima N, Narita A, Nishio N, Nakazawa Y, Iwafuchi H, Watanabe KI, Okuno Y (2017) Recurrent MYB rearrangement in blastic plasmacytoid dendritic cell neoplasm. Leukemia 31(7):1629\u20131633. https:\/\/doi.org\/10.1038\/leu.2017.101","journal-title":"Leukemia"},{"issue":"11","key":"6761_CR6","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.3324\/haematol.2010.026179","volume":"95","author":"AG Jegalian","year":"2010","unstructured":"Jegalian AG, Buxbaum NP, Facchetti F, Raffeld M, Pittaluga S, Wayne AS, Jaffe ES (2010) Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications. Haematologica 95(11):1873\u20131879. https:\/\/doi.org\/10.3324\/haematol.2010.026179","journal-title":"Haematologica"},{"issue":"7","key":"6761_CR7","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, Bejar R, Berti E, Busque L, Chan JKC, Chen W, Chen X, Chng WJ, Choi JK, Colmenero I, Coupland SE, Cross NCP, De Jong D, Elghetany MT, Takahashi E, Hochhaus A (2022) The 5th edition of the world health organization classification of haematolymphoid tumours: myeloid and Histiocytic\/Dendritic neoplasms. Leukemia 36(7):1703\u20131719. https:\/\/doi.org\/10.1038\/s41375-022-01613-1","journal-title":"Leukemia"},{"key":"6761_CR8","doi-asserted-by":"publisher","unstructured":"Pagano, L., Valentini, C. G., Pulsoni, A., Fisogni, S., Carluccio, P., Mannelli, F.,Lunghi, M., Pica, G., Onida, F., Cattaneo, C., Piccaluga, P. P., Di Bona, E., Todisco,E., Musto, P., Spadea, A., D\u2019Arco, A., Pileri, S., Leone, G., Amadori, S., Facchetti,F., \u2026 GIMEMA-ALWP (Gruppo Italiano Malattie EMatologiche dell\u2019Adulto, Acute Leukemia Working Party) (2013). Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study. Haematologica, 98(2), 239\u2013246. https:\/\/doi.org\/10.3324\/haematol.2012.072645","DOI":"10.3324\/haematol.2012.072645"},{"issue":"2\u20133","key":"6761_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/cac2.12014","volume":"40","author":"FM Zheng","year":"2020","unstructured":"Zheng FM, Zhang X, Li CF, Cheng YF, Gao L, He YL, Wang Y, Huang XJ (2020) Haploidentical- versus identical-sibling transplant for high-risk pediatric AML: A multi-center study. Cancer Commun (London England) 40(2\u20133):93\u2013104. https:\/\/doi.org\/10.1002\/cac2.12014","journal-title":"Cancer Commun (London England)"},{"issue":"2","key":"6761_CR10","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/bjh.14146","volume":"174","author":"L Pagano","year":"2016","unstructured":"Pagano L, Valentini CG, Grammatico S, Pulsoni A (2016) Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches. Br J Haematol 174(2):188\u2013202. https:\/\/doi.org\/10.1111\/bjh.14146","journal-title":"Br J Haematol"},{"key":"6761_CR11","doi-asserted-by":"publisher","first-page":"204062072412516","DOI":"10.1177\/20406207241251602","volume":"15","author":"C Gong","year":"2024","unstructured":"Gong C, Liu Y, Zhang M (2024) A systematic literature review of 74 Chinese blastic plasmacytoid dendritic cell neoplasm patients. Therapeutic Adv Hematol 15:20406207241251602. https:\/\/doi.org\/10.1177\/20406207241251602","journal-title":"Therapeutic Adv Hematol"},{"issue":"3","key":"6761_CR12","doi-asserted-by":"publisher","first-page":"e841","DOI":"10.1097\/HS9.0000000000000841","volume":"7","author":"L Pagano","year":"2023","unstructured":"Pagano L, Zinzani PL, Pileri S, Quaglino P, Cuglievan B, Berti E, Pemmaraju N, Onida F, Willemze R, Orfao A, Barosi G (2023) Unmet clinical needs and management recommendations for blastic plasmacytoid dendritic cell neoplasm: A Consensus-based position paper from an ad hoc international expert panel. HemaSphere 7(3):e841. https:\/\/doi.org\/10.1097\/HS9.0000000000000841","journal-title":"HemaSphere"},{"issue":"5","key":"6761_CR13","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3390\/cancers11050595","volume":"11","author":"MR Sapienza","year":"2019","unstructured":"Sapienza MR, Pileri A, Derenzini E, Melle F, Motta G, Fiori S, Calleri A, Pimpinelli N, Tabanelli V, Pileri S (2019) Blastic plasmacytoid dendritic cell neoplasm: state of the Art and prospects. Cancers 11(5):595. https:\/\/doi.org\/10.3390\/cancers11050595","journal-title":"Cancers"},{"issue":"5","key":"6761_CR14","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1097\/PAS.0000000000000156","volume":"38","author":"F Julia","year":"2014","unstructured":"Julia F, Dalle S, Duru G, Balme B, Vergier B, Ortonne N, Vignon-Pennamen MD, Costes-Martineau V, Lamant L, Dalac S, Delattre C, D\u00e9chelotte P, Courville P, Carlotti A, De Muret A, Fraitag S, Levy A, Mitchell A, Petrella T (2014) Blastic plasmacytoid dendritic cell neoplasms: clinico-immunohistochemical correlations in a series of 91 patients. Am J Surg Pathol 38(5):673\u2013680. https:\/\/doi.org\/10.1097\/PAS.0000000000000156","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"6761_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3390\/cancers17020221","volume":"17","author":"N Bakshi","year":"2025","unstructured":"Bakshi N, Hejazi A, Al-Maghraby A, Mugairi HA, Alotaibi A, Khogeer AS, Seliem H, Pandita RM, Raslan R, Aung H, P. P., Ohgami RS (2025) A multidisciplinary approach to diagnosing blastic plasmacytoid dendritic cell neoplasm (BPDCN): practical recommendations and insights from countries of the Gulf Cooperation Council. Cancers 17(2):221. https:\/\/doi.org\/10.3390\/cancers17020221","journal-title":"Cancers"},{"issue":"1","key":"6761_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/10428194.2021.1975192","volume":"63","author":"NR Wilson","year":"2022","unstructured":"Wilson NR, Bover L, Konopleva M, Han L, Neelapu S, Pemmaraju N (2022) CD303 (BDCA-2) - a potential novel target for therapy in hematologic malignancies. Leuk Lymphoma 63(1):19\u201330. https:\/\/doi.org\/10.1080\/10428194.2021.1975192","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"6761_CR17","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/bjd.12412","volume":"169","author":"F Julia","year":"2013","unstructured":"Julia F, Petrella T, Beylot-Barry M, Bagot M, Lipsker D, Machet L, Joly P, Dereure O, Wetterwald M, d\u2019Incan M, Grange F, Cornillon J, Tertian G, Maubec E, Saiag P, Barete S, Templier I, Aubin F, Dalle S (2013) Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients. Br J Dermatol 169(3):579\u2013586. https:\/\/doi.org\/10.1111\/bjd.12412","journal-title":"Br J Dermatol"},{"issue":"23","key":"6761_CR18","doi-asserted-by":"publisher","first-page":"5888","DOI":"10.3390\/cancers13235888","volume":"13","author":"CC Yin","year":"2021","unstructured":"Yin CC, Pemmaraju N, You MJ, Li S, Xu J, Wang W, Tang Z, Alswailmi O, Bhalla KN, Qazilbash MH, Konopleva M, Khoury JD (2021) Integrated clinical Genotype-Phenotype characteristics of blastic plasmacytoid dendritic cell neoplasm. Cancers 13(23):5888. https:\/\/doi.org\/10.3390\/cancers13235888","journal-title":"Cancers"},{"key":"6761_CR19","doi-asserted-by":"publisher","unstructured":"Renosi, F., Roggy, A., Giguelay, A., Soret, L., Viailly, P. J., Cheok, M., Biichle,S., Angelot-Delettre, F., Asnafi, V., Macintyre, E., Geffroy, S., Callanan, M., Petrella,T., Deconinck, E., Daguindau, E., Harrivel, V., Bouyer, S., Salaun, V., Saussoy, P.,Feuillard, J., \u2026 Garnache-Ottou, F. (2021). Transcriptomic and genomic heterogeneity in blastic plasmacytoid dendritic cell neoplasms: from ontogeny to oncogenesis. Blood advances, 5(5), 1540\u20131551. https:\/\/doi.org\/10.1182\/bloodadvances.2020003359","DOI":"10.1182\/bloodadvances.2020003359"},{"issue":"5","key":"6761_CR20","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1038\/s41375-022-01538-9","volume":"36","author":"M Khanlari","year":"2022","unstructured":"Khanlari M, Yin CC, Takahashi K, Lachowiez C, Tang G, Loghavi S, Bah I, Wang W, Konoplev S, Medeiros LJ, Pemmaraju N, Khoury JD, Wang SA (2022) Bone marrow clonal hematopoiesis is highly prevalent in blastic plasmacytoid dendritic cell neoplasm and frequently sharing a clonal origin in elderly patients. Leukemia 36(5):1343\u20131350. https:\/\/doi.org\/10.1038\/s41375-022-01538-9","journal-title":"Leukemia"},{"issue":"3","key":"6761_CR21","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1365-2141.2010.08556.x","volume":"153","author":"F Jardin","year":"2011","unstructured":"Jardin F, Ruminy P, Parmentier F, Troussard X, Vaida I, Stamatoullas A, Lepr\u00eatre S, Penther D, Duval AB, Picquenot JM, Courville P, Capiod JC, Tilly H, Bastard C, Marolleau JP (2011) TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasm. Br J Haematol 153(3):413\u2013416. https:\/\/doi.org\/10.1111\/j.1365-2141.2010.08556.x","journal-title":"Br J Haematol"},{"issue":"8","key":"6761_CR22","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/ajh.27737","volume":"100","author":"S Shimony","year":"2025","unstructured":"Shimony S, Luskin MR, Gangat N, LeBoeuf NR, Feraco AM, Lane AA (2025) Blastic plasmacytoid dendritic cell neoplasm (BPDCN): 2025 update on Diagnosis, Pathophysiology, risk Assessment, and management. Am J Hematol 100(8):1408\u20131422. https:\/\/doi.org\/10.1002\/ajh.27737","journal-title":"Am J Hematol"},{"issue":"5","key":"6761_CR23","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/s41375-024-02240-8","volume":"38","author":"A K\u00fcnstner","year":"2024","unstructured":"K\u00fcnstner A, Schwarting J, Witte HM, Xing P, Bernard V, St\u00f6lting S, Lohneis P, Janke F, Salehi M, Chen X, Kusch K, S\u00fcltmann H, Chteinberg E, Fischer A, Siebert R, von Bubnoff N, Merz H, Busch H, Feller AC, Gebauer N (2024) Genome-wide DNA methylation-analysis of blastic plasmacytoid dendritic cell neoplasm identifies distinct molecular features. Leukemia 38(5):1086\u20131098. https:\/\/doi.org\/10.1038\/s41375-024-02240-8","journal-title":"Leukemia"},{"key":"6761_CR24","doi-asserted-by":"publisher","unstructured":"Pemmaraju N (2024) BPDCN: state of the art. Hematology. American Society of Hematology. Education Program, 2024(1), 279\u2013286. https:\/\/doi.org\/10.1182\/hematology.2024000553","DOI":"10.1182\/hematology.2024000553"},{"issue":"22","key":"6761_CR25","doi-asserted-by":"publisher","first-page":"19204","DOI":"10.18632\/oncotarget.4146","volume":"6","author":"L Mart\u00edn-Mart\u00edn","year":"2015","unstructured":"Mart\u00edn-Mart\u00edn L, L\u00f3pez A, Vidriales B, Caballero MD, Rodrigues AS, Ferreira SI, Lima M, Almeida S, Valverde B, Mart\u00ednez P, Ferrer A, Candeias J, Ru\u00edz-Cabello F, Buadesa JM, Sempere A, Villamor N, Orfao A, Almeida J (2015) Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile. Oncotarget 6(22):19204\u201319216. https:\/\/doi.org\/10.18632\/oncotarget.4146","journal-title":"Oncotarget"},{"issue":"7","key":"6761_CR26","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/sj.bmt.1704215","volume":"32","author":"P Reimer","year":"2003","unstructured":"Reimer P, R\u00fcdiger T, Kraemer D, Kunzmann V, Weissinger F, Zettl A, M\u00fcller-Hermelink K, H., Wilhelm M (2003) What is CD4\u2009+\u2009CD56\u2009+\u2009malignancy and how should it be treated? Bone Marrow Transplant 32(7):637\u2013646. https:\/\/doi.org\/10.1038\/sj.bmt.1704215","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"6761_CR27","doi-asserted-by":"publisher","first-page":"890","DOI":"10.3904\/kjim.2015.406","volume":"32","author":"HS Kim","year":"2017","unstructured":"Kim HS, Kim HJ, Kim SH, Choi JY, Ko YH, Kim WS, Jung CW, Kim SJ (2017) Clinical features and treatment outcomes of blastic plasmacytoid dendritic cell neoplasm: a single-center experience in Korea. Korean J Intern Med 32(5):890\u2013899. https:\/\/doi.org\/10.3904\/kjim.2015.406","journal-title":"Korean J Intern Med"},{"key":"6761_CR28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2147\/BLCTT.S132060","volume":"7","author":"AM Trottier","year":"2017","unstructured":"Trottier AM, Cerquozzi S, Owen CJ (2017) Blastic plasmacytoid dendritic cell neoplasm: challenges and future prospects. Blood Lymphatic Cancer: Targets Therapy 7:85\u201393. https:\/\/doi.org\/10.2147\/BLCTT.S132060","journal-title":"Blood Lymphatic Cancer: Targets Therapy"},{"issue":"4","key":"6761_CR29","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1586\/ehm.12.33","volume":"5","author":"PP Piccaluga","year":"2012","unstructured":"Piccaluga PP, Paolini S, Sapienza MR, Pileri SA (2012) Blastic plasmacytoid dendritic cell neoplasm: is it time to redefine the standard of care? Expert Rev Hematol 5(4):353\u2013355. https:\/\/doi.org\/10.1586\/ehm.12.33","journal-title":"Expert Rev Hematol"},{"issue":"1","key":"6761_CR30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41409-021-01478-5","volume":"57","author":"Q Bashir","year":"2022","unstructured":"Bashir Q, Milton DR, Popat UR, Kebriaei P, Hosing C, Khouri IF, Rezvani K, Nieto Y, Oran B, Srour SA, Saini NY, Olson AL, Ahmed S, Al-Atrash G, Rondon G, Konopleva MY, Champlin RE, Shpall EJ, Qazilbash MH, Pemmaraju N (2022) Allogeneic hematopoietic cell transplantation for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN). Bone Marrow Transplant 57(1):51\u201356. https:\/\/doi.org\/10.1038\/s41409-021-01478-5","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"6761_CR31","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/MPH.0000000000000964","volume":"39","author":"MJ Kim","year":"2017","unstructured":"Kim MJ, Nasr A, Kabir B, de Nanassy J, Tang K, Menzies-Toman D, Johnston D, Demellawy E, D (2017) Pediatric blastic plasmacytoid dendritic cell neoplasm: A systematic literature review. J Pediatr Hematol Oncol 39(7):528\u2013537. https:\/\/doi.org\/10.1097\/MPH.0000000000000964","journal-title":"J Pediatr Hematol Oncol"},{"issue":"5","key":"6761_CR32","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/s41409-025-02528-y","volume":"60","author":"J Zhou","year":"2025","unstructured":"Zhou J, Wang F, Yang S, Zhang Y, Liu Y, Zhao T, Sun Y, Zhang S, Mo X, Chen H, Suo P, Wen L, Jia J, Wang J, Gale RP, Lu J (2025) Survival outcomes between haploidentical stem cell transplantation and chemotherapy for blastic plasmacytoid dendritic cell neoplasm. Bone Marrow Transplant 60(5):568\u2013572. https:\/\/doi.org\/10.1038\/s41409-025-02528-y","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"6761_CR33","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1158\/1078-0432.CCR-19-2329","volume":"26","author":"EY Jen","year":"2020","unstructured":"Jen EY, Gao X, Li L, Zhuang L, Simpson NE, Aryal B, Wang R, Przepiorka D, Shen YL, Leong R, Liu C, Sheth CM, Bowen S, Goldberg KB, Farrell AT, Blumenthal GM, Pazdur R (2020) FDA approval summary: Tagraxofusp-erzs for treatment of blastic plasmacytoid dendritic cell neoplasm. Clin Cancer Research: Official J Am Association Cancer Res 26(3):532\u2013536. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-2329","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"issue":"26","key":"6761_CR34","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1200\/JCO.22.00034","volume":"40","author":"N Pemmaraju","year":"2022","unstructured":"Pemmaraju N, Sweet KL, Stein AS, Wang ES, Rizzieri DA, Vasu S, Rosenblat TL, Brooks CL, Habboubi N, Mughal TI, Kantarjian H, Konopleva M, Lane AA (2022) Long-Term benefits of Tagraxofusp for patients with blastic plasmacytoid dendritic cell neoplasm. J Clin Oncology: Official J Am Soc Clin Oncol 40(26):3032\u20133036. https:\/\/doi.org\/10.1200\/JCO.22.00034","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"issue":"1","key":"6761_CR35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13045-018-0604-6","volume":"11","author":"W Sun","year":"2018","unstructured":"Sun W, Liu H, Kim Y, Karras N, Pawlowska A, Toomey D, Kyono W, Gaynon P, Rosenthal J, Stein A (2018) First pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three cases. J Hematol Oncol 11(1):61. https:\/\/doi.org\/10.1186\/s13045-018-0604-6","journal-title":"J Hematol Oncol"},{"issue":"1","key":"6761_CR36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/jha2.856","volume":"5","author":"N Pemmaraju","year":"2024","unstructured":"Pemmaraju N, Cuglievan B, Lasky J, Kheradpour A, Hijiya N, Stein AS, Meshinchi S, Mullen CA, Angelucci E, Vinti L, Mughal TI, Pawlowska AB (2024) Efficacy and manageable safety of Tagraxofusp in blastic plasmacytoid dendritic cell neoplasm: a case series of pediatric and adolescent\/young adult patients. EJHaem 5(1):61\u201369. https:\/\/doi.org\/10.1002\/jha2.856","journal-title":"EJHaem"},{"issue":"2","key":"6761_CR37","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1158\/2159-8290.CD-16-0999","volume":"7","author":"J Montero","year":"2017","unstructured":"Montero J, Stephansky J, Cai T, Griffin GK, Cabal-Hierro L, Togami K, Hogdal LJ, Galinsky I, Morgan EA, Aster JC, Davids MS, LeBoeuf NR, Stone RM, Konopleva M, Pemmaraju N, Letai A, Lane AA (2017) Blastic plasmacytoid dendritic cell neoplasm is dependent on BCL2 and sensitive to venetoclax. Cancer Discov 7(2):156\u2013164. https:\/\/doi.org\/10.1158\/2159-8290.CD-16-0999","journal-title":"Cancer Discov"},{"issue":"2","key":"6761_CR38","doi-asserted-by":"publisher","first-page":"E62","DOI":"10.1002\/ajh.26417","volume":"97","author":"N Gangat","year":"2022","unstructured":"Gangat N, Konopleva M, Patnaik MM, Jabbour E, DiNardo C, Al-Kali A, Foran JM, Granroth GL, Olteanu H, Kadia T, Tefferi A, Pemmaraju N (2022) Venetoclax and hypomethylating agents in older\/unfit patients with blastic plasmacytoid dendritic cell neoplasm. Am J Hematol 97(2):E62\u2013E67. https:\/\/doi.org\/10.1002\/ajh.26417","journal-title":"Am J Hematol"},{"key":"6761_CR39","doi-asserted-by":"publisher","first-page":"100313","DOI":"10.1016\/j.lrr.2022.100313","volume":"17","author":"D Abla","year":"2022","unstructured":"Abla D, Abboud MR, Noun D, Tarek N, Pemmaraju N (2022) Hyper-CVAD combined with venetoclax for relapsed pediatric blastic plasmacytoid dendritic cell neoplasm (BPDCN): A case report and literature review. Leuk Res Rep 17:100313. https:\/\/doi.org\/10.1016\/j.lrr.2022.100313","journal-title":"Leuk Res Rep"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06761-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-06761-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06761-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T03:33:54Z","timestamp":1770262434000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-06761-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,17]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["6761"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-06761-3","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,17]]},"assertion":[{"value":"26 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}